EFA – Discussions with the Dutch Presidency of the EU
Given that the Dutch Presidency of the Council of the EU has identified improving occupational health and safety as one of their working priorities, the European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) met with the leading team of the Presidency to discuss the revision of the Directive on carcinogens or mutagens at work, which is scheduled for May.
During this important meeting, EFA highlighted that some risk factors, such as exposure to second hand smoke, bad indoor air quality and other chemicals in our daily life, are common to cancers and respiratory diseases.
EFA will voice the allergy and respiratory patients’ perspective throughout the revision of this legislation to ensure their needs are taken into account. The Dutch Presidency is organising a conference on banning work-related cancers on the 23-25 May in Amsterdam.
For more information, please click here.
The European Public Health Alliance (EPHA) has raised public health concerns on the regulatory cooperation clause in the much debated upon Transatlantic Trade and Investment Partnership (TTIP) between the EU and the United States.
In a press release released, EPHA indicated that it maintains its reservations about the Regulatory Cooperation and Good Regulatory Practices in the trade agreement, which the aim of both cutting red tape and costs. Yet, the risks of increased bureaucracy, decreased transparency and reduced democratic accountability still hover in the EU if these clauses are adopted. Moreover, current TTIP proposals risk institutionalising corporate lobbying.
For the full EPHA press release, please click here.
Originally posted on 22 April 2016